Shares of Wanbury Limited fell over 7% during the trading session onTuesday, July 21 after the pharma firm informed that one of its facilities received six observations from US Food and Drug Administration.
Wanbury shares declined 7.6% intraday to Rs 314.05 apiece. The scrip was trading 2.91% lower by 12:10 pm, while the benchmark Nifty 50 index was down 0.26%.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
In an exchange filing on Monday, July 20, Wanburt said that the US FDA conducted inpection at its facility at Tanuku, West Godavari District, Andhra Pradesh from July 13 to July 17. Following the inspection, the drug regulator issued Form 483 with six observations.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
The filing read, "We hereby notify that a routine current Good Manufacturing Practices ( cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the company's facility at Tanuku, West Godavari District, Andhra Pradesh during the period from July 13, 2026 to July 17, 2026. At the conclusion of the inspection, the U.S.FDA has issued a Form 483 with six observations."
It added, "The Company will respond to these observations to FDA within the stipulated time."
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
